The ER-negative (ER-) breast cancer tissue samples had significantly lower PER1 gene expression than the ER-positive breast cancer tissue samples (ER+) (β-coefficient -0.291 p = 0.005). This evidence concerns the gene PER1 and breast carcinoma.